David E Kelley MD
Diabetes, Lipid Metabolism
Vice President, Franchise Integrator for Diabetes & Obesity
Join to View Full Profile
3601 5th AvePittsburgh, PA 15213
Phone+1 412-383-8700
Join Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 3 invites waiting! - Read the latest clinical news, personalized to your specialty.
Summary
- Dr. David Kelley, MD is an endocrinologist in Pittsburgh, Pennsylvania. He is a Vice President at Franchise Integrator for Diabetes & Obesity.
Education & Training
Mayo Clinic College of Medicine and Science (Rochester)Fellowship, Endocrinology, Diabetes, and Metabolism, 1985 - 1987
University of MarylandResidency, Internal Medicine, 1979 - 1981
Oregon Health & Science University (OHSU Health)Internship, Internal Medicine, 1978 - 1979
University of Maryland School of MedicineClass of 1978
Publications & Presentations
PubMed
- 2 citationsMuscle insulin resistance in type 1 diabetes with coronary artery disease.Katherine V. Williams, Christina M. Shay, Julie C. Price, Bret H. Goodpaster, Carol Kelley
Diabetologia. 2020-09-14 - 27 citationsProspective evaluation of insulin and incretin dynamics in obese adults with and without diabetes for 2 years after Roux-en-Y gastric bypassJonathan Q. Purnell, Geoffrey S. Johnson, Abdus S. Wahed, Chiara Dalla Man, Francesca Piccinini
Diabetologia. 2018-02-10 - 35 citationsChanges in skeletal muscle and organ size after a weight-loss intervention in overweight and obese type 2 diabetic patients.Dympna Gallagher, David E. Kelley, John C. Thornton, Lawrence M. Boxt, Xavier Pi-Sunyer
The American Journal of Clinical Nutrition. 2017-01-01
Press Mentions
Potential Diabetes Target Makes Subtle Changes with Big Impact on Metabolic HealthJuly 5th, 2019
Tiny Change Has Big Effects, Reverses Prediabetes in MiceJuly 4th, 2019
Subtle Chemical Shift Reverses Prediabetes in Merck-Partnered Mouse TrialJuly 2nd, 2019- Join now to see all
